ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 617823 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 617823; 2) Community: the network communities that were significantly associated with the response to NSC 617823; 3) Molecule: the relationships between components within communities and NSC 617823; 4) MDR: the compounds that were significantly associated with the NSC 617823.

NSC Compound Enrichment Correlation
NSC 113497 16,17-Seco-24-nor-5.alpha.,13.alpha.,14.beta.,17.alpha.-chola-1,20,22-trien-16-oic acid, 14,15.beta.:21,23-diepoxy-7.alpha.,17-dihydroxy-4,4,8-trimethyl-3-oxo-, 16,17-lactone, acetate (8CI) 0.0396077140933377 0.20578437
NSC 126228 Ethanesulfonic acid, compd. with m-[4-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) 0.0396077140933377 0.1831036
NSC 13151 Null 0.0396077140933377 0.32947107
NSC 185065 Hydrazinecarbothioamide, 2-[(5-hydroxy-2-pyridinyl)methylene]-N-(3-pyridinyl)- 0.0396077140933377 0.47652097
NSC 18805 .gamma.-Thujaplicine 0.0396077140933377 0.35573818
NSC 22709 v-Triazolo[4,5-d]pyrimidin-7-ol 0.0396077140933377 0.50835368
NSC 23925 Null 0.0396077140933377 0.38847835
NSC 303861 L-Cysteine analog 0.0396077140933377 0.72092773
NSC 30722 Pyrimidine, 2,4,6-trichloro-5-methyl- 0.0396077140933377 0.591633
NSC 339137 PHYSALOLACTONE 0.0396077140933377 0.57978247
Total:139  Current:120    [First] [Prev] [Next] [Last]